A plausible explanation for this observation is that our mice cohort modelled a rather mild NAFLD development, so that the addition of plasma CK-18, which represents advanced stages of NAFLD, did not effectively improve the analysis. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.